Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Podcast Sep 2022 Ethics Teaching and Learning: Updated Lessons for Clinicians and Students From a Transgender Patient Ryan Sallans, MA joins Ethics Teaching and Learning to discuss how to make health care spaces welcoming for LGBTQ+ patients. Podcast Aug 2022 Author Interview: “How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients” Dr Ximena Lopez joins Ethics Talk to discuss her article, coauthored with Antonio D. Garcia: “How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients.” Podcast Apr 2023 Author Interview: “Should Clinicians Care About How Food Behaviors Express Gender Identity?” Dr Whitney Riley Linsenmeyer joins Ethics Talk to discuss her article: “Should Clinicians Care About How Food Behaviors Express Gender Identity?” Podcast Aug 2022 Author Interview: “When Is Iatrogenic Harm Negligent?” Ramya Sampath joins Ethics Talk to discuss her article: “When Is Iatrogenic Harm Negligent?” Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Case and Commentary Nov 2024 How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe? Jennifer C. Jones, PhD, LCSW and Aisha Mohammed, MFT, LMFT This commentary on a case considers how clinicians can help nonbinary patients minimize potential harms of psychedelics. AMA J Ethics. 2024;26(11):E842-849. doi: 10.1001/amajethics.2024.842. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Podcast Sep 2022 Ethics Teaching and Learning: Updated Lessons for Clinicians and Students From a Transgender Patient Ryan Sallans, MA joins Ethics Teaching and Learning to discuss how to make health care spaces welcoming for LGBTQ+ patients.
Podcast Aug 2022 Author Interview: “How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients” Dr Ximena Lopez joins Ethics Talk to discuss her article, coauthored with Antonio D. Garcia: “How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients.”
Podcast Apr 2023 Author Interview: “Should Clinicians Care About How Food Behaviors Express Gender Identity?” Dr Whitney Riley Linsenmeyer joins Ethics Talk to discuss her article: “Should Clinicians Care About How Food Behaviors Express Gender Identity?”
Podcast Aug 2022 Author Interview: “When Is Iatrogenic Harm Negligent?” Ramya Sampath joins Ethics Talk to discuss her article: “When Is Iatrogenic Harm Negligent?”
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Case and Commentary Nov 2024 How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe? Jennifer C. Jones, PhD, LCSW and Aisha Mohammed, MFT, LMFT This commentary on a case considers how clinicians can help nonbinary patients minimize potential harms of psychedelics. AMA J Ethics. 2024;26(11):E842-849. doi: 10.1001/amajethics.2024.842.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
